Effects of Pancreatic Fistula After Minimally Invasive and Open Pancreatoduodenectomy
C.L. Bruna(Amsterdam University Medical Centers), Mahsoem Ali(Amsterdam Neuroscience), Mathieu D’Hondt(AZ Groeninge), Yi‐Ming Shyr(National Yang Ming Chiao Tung University), Hjalmar C. van Santvoort(University Medical Center Utrecht), Olivier Saint‐Marc(Centre hospitalier universitaire d'Orléans), Ugo Boggi(Azienda Ospedaliera Universitaria Pisana), Marc G. Besselink(Amsterdam Neuroscience), L. Jones(Fondazione Poliambulanza Istituto Ospedaliero), Koop Bosscha(Jeroen Bosch Ziekenhuis), Cheng‐Ming Peng, Bas Groot Koerkamp, Clarissa Ferrari(Fondazione Poliambulanza Istituto Ospedaliero), Yan‐Shen Shan(National Cheng Kung University Hospital), Kongyuan Wei(Heidelberg University), Guiseppe Fusai(Royal Free London NHS Foundation Trust), Alberto Manzoni(Collaborative Group (United States)), Safi Dokmak(Université Paris Cité), Marcel Autran C. Machado, Baiyong Shen(Ruijin Hospital), Bergþór Björnsson(Linköping University), Uwe A. Wittel(University of Freiburg), Bert A. Bonsing(Leiden University Medical Center), Misha Luyer(Radboud University Nijmegen), Luca Moraldi, Anouk M. L. H. Emmen(Fondazione Poliambulanza Istituto Ospedaliero), Claudio Bnà, Mustafa Kerem(Gazi University), Chang Moo Kang, Daan J. Lips(Medisch Spectrum Twente), Régis Souche, Jin‐Young Jang(Seoul National University), Robert P. Sutcliffe(University Hospitals Birmingham NHS Foundation Trust), Rong Liu(Chinese People's Liberation Army), Mehmet Fatih Can, Igor Khatkov(Moscow Clinical Scientific Center), Régis Fara, Sebastiaan Festen(OLVG), Mohammad Abu Hilal(University of Jordan), I. Quintus Molenaar(University Medical Center Utrecht), Giovanni Ferrari, Thilo Hackert(Universität Hamburg), Steve White(Freeman Hospital), Tobias Keck(Krankenhaus der Augustinerinnen)
Cited by 22
Related Papers
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
|Nature Reviews Gastroenterology & Hepatology|2020|2.5k
Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial
|Journal of Clinical Oncology|2020|1.1k
FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis
|The Lancet Oncology|2016|914